You are here

Article Text

Article menu
Download PDFPDF
Leading article
Global hepatitis, migration and its impact on Western healthcare

https://doi.org/10.1136/gut.2009.206763

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests Dr Furqaan Ahmed has none to declare. Professor Foster has received funding from companies that manufacture drugs used to treat viral hepatitis. Specifically he has received consultancy fees from Roche, Novartis, Chughai, Tibotec, Gilead and BMS and he has received grant funding from Roche, Chughai and Gilead.

    • Provenance and peer review Commissioned; not externally peer reviewed.